Evernow

Evernow is a telehealth company based in San Francisco, California, focused on menopause care. It provides online medical consultations, personalised treatment plans, and prescription medications for women experiencing perimenopause and menopause. The company aims to address the gap in menopause care, as 75% of women who seek treatment do not receive adequate support.

Evernow offers access to menopause-certified clinicians through 24/7 messaging and video consultations. The treatment includes hormonal and non-hormonal therapies, weight management solutions, and skin and hair treatments. Prescription medications such as estradiol patches, progesterone, and compounded semaglutide for weight loss are available. The service is subscription-based, starting at $35 per month, with flexible plans that are FSA/HSA eligible.

The company accepts insurance for video consultations through providers like BlueCross BlueShield, UnitedHealth, Aetna, and Anthem. Patients can choose pharmacy pickup or home delivery for their medications. Evernow also provides research-based menopause support, tracking symptoms over time to improve care.

A key part of Evernow’s work is its menopause study, which has surveyed over 100,000 women. The research highlights that common menopause symptoms include weight changes, sleep disruption, fatigue, and brain fog, with severity varying by age and ethnicity. The study also examines factors like smoking, BMI, and hysterectomy effects on menopause symptoms.

Evernow has raised $28.5 million in Series A funding, giving it an estimated market cap of around $28.5 million as a privately held company. Investors include NEA, 8VC, Gwyneth Paltrow, Drew Barrymore, Cameron Diaz, and Gwynne Shotwell.

Evernow was founded to address the lack of adequate menopause care for women. The company was established in San Francisco, California, as a telehealth platform focused on providing accessible, evidence-based treatment for perimenopause and menopause. It was developed to close the treatment gap in menopause care, as studies showed that a significant percentage of women seeking medical help for menopause symptoms did not receive appropriate support.

The company was built on the principle of using technology to improve healthcare delivery. It introduced an online consultation model where women could connect with certified menopause specialists through video calls and messaging. The goal was to eliminate barriers such as long wait times and lack of medical expertise in menopause care. The service was designed to be available 24/7, providing women with timely support.

Evernow’s core treatment offerings included both hormonal and non-hormonal therapies. It provided prescription medications such as estradiol patches, progesterone, and compounded semaglutide for weight management. The platform also included treatment for skin and hair health issues associated with menopause. The company structured its services as a subscription model, starting at $35 per month, allowing flexibility in treatment plans. The service was also made FSA/HSA eligible to increase accessibility.

To support its expansion, Evernow raised $28.5 million in a Series A funding round. The investment was led by NEA and 8VC, with participation from investors including Gwyneth Paltrow, Drew Barrymore, Cameron Diaz, and Gwynne Shotwell. This funding helped scale operations and improve the platform’s reach. The company continued developing its research capabilities, conducting a large-scale menopause study that surveyed over 100,000 women. The study provided insights into common symptoms, severity levels, and factors influencing menopause experiences, such as smoking, BMI, and hysterectomy effects.

Evernow expanded its insurance coverage to include providers such as BlueCross BlueShield, UnitedHealth, Aetna, and Anthem. It also improved medication delivery options, allowing patients to choose pharmacy pickup or home delivery. The company maintained a focus on improving the quality of menopause care by tracking patient symptoms and adjusting treatments based on real-time data.

Currently, Evernow continues to operate as a leading menopause telehealth platform. It provides structured, science-backed treatments while expanding its research initiatives. The company has between 11-50 employees and remains privately held with an estimated market cap of $28.5 million. It aims to further improve access to menopause care, offering women a comprehensive, technology-driven approach to managing symptoms and long-term health risks.

Evernow’s mission is to provide accessible, science-backed menopause care for women. The company aims to bridge the gap in menopause treatment by offering expert medical support through a digital platform. By providing personalised care plans, evidence-based treatments, and 24/7 access to certified menopause clinicians, Evernow ensures that women receive timely and effective solutions. The organisation focuses on making healthcare convenient, affordable, and supported by medical research. Evernow is committed to improving long-term health outcomes by addressing menopause symptoms and related risks. Through technology and medical expertise, it seeks to empower women to manage their health with confidence.

Evernow envisions a future where every woman has access to high-quality menopause care without barriers. The company aims to redefine menopause treatment by making expert medical support widely available through digital healthcare solutions. It seeks to eliminate the challenges women face in accessing proper care, ensuring that menopause is recognised as an important health phase requiring attention. Evernow plans to continue advancing research in menopause care and integrating new medical findings into its treatments. By prioritising accessibility, affordability, and innovation, Evernow strives to create a healthcare system where menopause care is standard, effective, and easily accessible for all women.

Evernow has been recognised for its innovative approach to menopause care. It has received funding from leading investors, including NEA and 8VC, showing strong industry trust. The company’s menopause study, involving over 100,000 women, is one of the largest in its field, contributing valuable research to women's health. Evernow has been featured in health and technology publications for improving access to menopause treatment. Its personalised, digital healthcare model has been praised for making expert care more accessible. Investors such as Gwyneth Paltrow and Drew Barrymore have highlighted the platform's impact, further validating its importance in healthcare.

Evernow provides a range of healthcare services focused on menopause treatment. It offers digital medical consultations, personalised treatment plans, and prescription medications designed to help women manage perimenopause and menopause symptoms. The company combines technology with medical expertise to make menopause care accessible, affordable, and effective.

One of Evernow’s key services is online access to certified menopause specialists. Women can connect with doctors through video consultations or 24/7 messaging. This allows them to receive expert medical advice without the need for in-person visits. The service provides continuous support, enabling women to ask questions, track their symptoms, and adjust their treatments as needed.

Evernow offers a variety of treatments, including hormone replacement therapy (HRT). This includes estradiol patches, estradiol pills, vaginal estradiol tablets, progesterone, and norethindrone. These medications help balance hormone levels and relieve symptoms such as hot flashes, night sweats, mood swings, and sleep disturbances. Vaginal estrogen cream is also available for treating vaginal dryness and discomfort.

For women who prefer non-hormonal options, Evernow provides alternative treatments such as Veozah, Femistry, and paroxetine. These medications help manage menopause symptoms without the use of hormones, making them suitable for women who cannot or do not wish to take hormone therapy.

Evernow also offers treatments for skin and hair health. Menopause can lead to hair thinning, hair loss, and skin changes, so the company provides solutions such as oral minoxidil, topical finasteride and minoxidil solution, facial estriol cream, and tretinoin face cream. These treatments help improve hair growth and maintain skin health during menopause.

Weight management is another key service offered by Evernow. The company provides prescription medications such as Ozempic®, Wegovy®, Zepbound®, Mounjaro®, and compounded semaglutide in injection and oral drop forms. These medications help improve metabolic health and assist with weight loss, addressing common menopause-related weight changes.

Evernow’s services are available through a subscription-based model. The monthly plan costs $49, while the three-month plan is priced at $43 per month, and the yearly plan offers the best value at $35 per month. All plans are FSA/HSA eligible, making them accessible for women using health savings accounts. The company also provides discounts on Talkspace therapy for mental health support.

To make treatment more accessible, Evernow accepts insurance for video consultations through providers such as BlueCross BlueShield, UnitedHealth, Aetna, and Anthem. Medications can be picked up from local pharmacies or delivered directly to patients' homes. The service is designed to be flexible, allowing women to manage their care conveniently through an online platform or mobile app.

In addition to providing treatments, Evernow conducts research on menopause to improve healthcare solutions. It has collected data from over 100,000 women, studying the severity of symptoms and the effectiveness of various treatments. The company continues to develop new ways to enhance menopause care and ensure that women receive proper medical support.

Evernow’s approach combines expert medical care with digital convenience, making menopause treatment more effective and accessible for women everywhere.